Stay updated on ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical trial for ARV-110 in metastatic castration-resistant prostate cancer, including inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference18%
- Check30 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.14.4) and a new last update date of March 14, 2025, replacing the previous estimated update date of March 25, 2025, and the prior revision version (v2.14.3).SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has updated its certification and extension dates, with new dates added for submissions and postings, and a revision update from v2.14.2 to v2.14.3.SummaryDifference0.5%
- Check52 days agoChange DetectedThe page has updated its dates and stock availability, with the removal of older dates and a slight change in stock numbers.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.